A Southwest Oncology Group phase II trial of recombinant tumor necrosis factor in metastatic breast cancer.
Helson
L
L
D001943:Breast Neoplasms / Q000628:therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
D014409:Tumor Necrosis Factor-alpha